Prospective Clinical Assessment Study in Children with Hypochondroplasia: ACCEL
Primary Objective
To collect baseline Height Velocity of children with HCH being considered for future enrollment in interventional studies sponsored by QED Therapeutics

Description
This is a prospective, non-interventional clinical assessment study to collect data on children aged 2.5 to <17 years with HCH, which will contribute to the characterization of the natural history of children with HCH. This study is designed to evaluate study participants over a period of time (minimum of 6 months and maximum of 2 years) and to collect baseline data prior to potential enrollment in a QED-sponsored interventional study.
Details
Locations
Childrens Hospital Colorado
Principal Investigator

Klane White
Study ID
Protocol Number: 24-0425
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers